What is Cabio Biotech (Wuhan) Co Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cabio Biotech (Wuhan) Co's Average Total Inventories for the quarter that ended in Mar. 2025 was ¥141.9 Mil. Cabio Biotech (Wuhan) Co's Revenue for the
three
months ended in Mar. 2025 was ¥156.0 Mil.
Cabio Biotech (Wuhan) Co's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.91.
Cabio Biotech (Wuhan) Co's Inventory-to-Revenue for the quarter that ended in Mar. 2025
increased
from Dec. 2024 (0.80) to Dec. 2024 (0.91)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Cabio Biotech (Wuhan) Co's Days Inventory for the
three
months ended in Mar. 2025 was 162.03.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cabio Biotech (Wuhan) Co's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.56.
Cabio Biotech (Wuhan) Co Inventory-to-Revenue Historical Data
The historical data trend for Cabio Biotech (Wuhan) Co's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Cabio Biotech (Wuhan) Co Inventory-to-Revenue Chart
Competitive Comparison of Cabio Biotech (Wuhan) Co's Inventory-to-Revenue
For the Biotechnology subindustry, Cabio Biotech (Wuhan) Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cabio Biotech (Wuhan) Co's Inventory-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Cabio Biotech (Wuhan) Co's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Cabio Biotech (Wuhan) Co's Inventory-to-Revenue falls into.
Cabio Biotech (Wuhan) Co Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cabio Biotech (Wuhan) Co's Inventory-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cabio Biotech (Wuhan) Co (SHSE:688089) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Cabio Biotech (Wuhan) Co's Days Inventory for the
three
months ended in Mar. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cabio Biotech (Wuhan) Co Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Cabio Biotech (Wuhan) Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Cabio Biotech (Wuhan) Co Ltd is a biotechnology company, engaged in Research & Development, production and sales of polyunsaturated fatty acids ARA, algae oil DHA and SA, natural B-carotene and other series products. The products are used in infant formula, dietary nutrition supplements and health Food, special medical formula food and other fields. The company's product sales area covers China, the United States, Europe, Australia, New Zealand, South Korea, and Southeast Asia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:688089 has been successfully added to your 